Breast Cancer Awareness Month

Hope, Progress & the Power of Early Detection

October is Breast Cancer Awareness Month, a time when pink ribbons appear everywhere. But behind those ribbons are real women, families, and stories of courage, uncertainty, healing, and hope.

At Blue Skies Nursing, we help people navigate health care when life becomes complicated. One thing we have learned is that knowledge is powerful. Understanding your risk, keeping up with appropriate screenings, and asking questions can make a meaningful difference.

This year, there is encouraging progress to share.

Breast Cancer Care Is Becoming More Personal

We now know that breast cancer is not one single disease. Two women may receive the same diagnosis but have cancers that behave very differently.

Today, physicians can use hormone receptors, HER2 status, genetic mutations, tumor characteristics, and other information to help determine which treatments are most likely to work for an individual patient.

This more personalized approach is helping doctors move away from treating all breast cancers alike and toward targeting the specific characteristics of each cancer.

Don't Overlook Breast Density

Breast density has become an important part of the screening conversation. Dense breast tissue can make cancer more difficult to see on a mammogram and is also associated with an increased risk of developing breast cancer.

Since September 2024, federal regulations require mammography facilities to notify patients about their breast density in their results.

So, when your mammogram report arrives, don't stop reading when you see the word "normal." Read the entire report.

If you have dense breasts, ask your health care provider what that means for you and whether your personal risk factors suggest that additional screening should be considered.

Screening Is Getting Smarter

Researchers continue to look for ways to detect breast cancer earlier and more accurately.

Studies are evaluating 3-D mammography, contrast-enhanced mammography, and improved screening approaches for women with dense breasts. Artificial intelligence is also being studied as a tool to help radiologists identify subtle abnormalities on mammograms.

The goal isn't to replace your radiologist. It is to give health care providers better tools to find concerning changes as early as possible.

A Blood Test May Help Guide Treatment

One particularly interesting area of research involves circulating tumor DNA, or ctDNA.

Cancer cells can release tiny fragments of DNA into the bloodstream. Newer blood tests, sometimes called "liquid biopsies," can look for certain genetic changes in that DNA.

In September 2026, the FDA granted accelerated approval to camizestrant in combination with a CDK4/6 inhibitor for certain patients with advanced or metastatic hormone receptor-positive, HER2-negative breast cancer after an ESR1 mutation is detected during treatment. A blood-based companion diagnostic can be used to identify this mutation.

For certain patients, this type of testing may help physicians recognize changes in a cancer and adjust treatment based on its evolving biology.

New Treatment Options Continue to Emerge

Another area of progress involves antibody-drug conjugates, medications designed to target certain cancer cells and deliver cancer-fighting drugs more precisely.

In 2026, the FDA approved new uses for trastuzumab deruxtecan (Enhertu) for certain people with early-stage HER2-positive breast cancer.

There has also been progress for triple-negative breast cancer. In May 2026, the FDA approved datopotamab deruxtecan (Datroway) for certain adults with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 immunotherapy.

These treatments are not appropriate for everyone, but each new option gives oncology teams another tool to consider when developing an individualized treatment plan.

Caring for the Person, Not Just the Cancer

Breast cancer research is also focusing more attention on life during and after treatment.

Survivors may experience fatigue, weakness, lymphedema, medication side effects, sleep problems, emotional stress, changes in mobility, or fear of recurrence. Researchers are increasingly studying these concerns alongside cancer treatment and survival.

At Blue Skies Nursing, this idea is especially meaningful to us. Good health care should care for the whole person, not just the diagnosis.

Make October a Month of Action

Breast Cancer Awareness Month is a good reminder to take a few minutes for yourself and the women you love.

Know your family history. Talk with your health care provider about your individual breast cancer risk and the screening schedule that is right for you. Read your mammogram report, including information about breast density. And don't ignore a new lump, skin or nipple change, unusual discharge, or another breast change simply because your last mammogram was normal.

Then check in with someone you love.

Remind your sister to schedule her mammogram. Offer to drive your mom. Sit with a friend who is waiting for results. Bring dinner to someone going through treatment.

Sometimes the most meaningful care comes from simply showing up.

There is genuine reason for hope. Screening is becoming more sophisticated, treatments are becoming more individualized, and researchers continue to find new ways to detect and treat breast cancer.

This October, wear the pink ribbon if it has meaning for you. But also make the appointment, ask the questions, know your risk, and encourage someone you love to do the same.

Awareness matters, but action can be lifesaving. If you don't know where to start or need assistance in your journey, schedule a free consultation with us.

Schedule Your FREE Consulation

Blue Skies Nursing is proud to support women and families throughout our Colorado communities. This article is intended for general education and should not replace individualized advice from your physician or other health care provider.

---

Together... we've got this!